BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31292158)

  • 41. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.
    Kim TH; Leslie P; Zhang Y
    Oncotarget; 2014 Feb; 5(4):860-71. PubMed ID: 24658219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression.
    Dai MS; Sun XX; Lu H
    J Biol Chem; 2010 Apr; 285(17):12587-94. PubMed ID: 20194507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
    Pan W; Issaq S; Zhang Y
    PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth inhibitory effects of large subunit ribosomal proteins in melanoma.
    Kardos GR; Dai MS; Robertson GP
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):801-12. PubMed ID: 24807543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
    Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
    Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis.
    Dönig J; Mende H; Davila Gallesio J; Wagner K; Hotz P; Schunck K; Piller T; Hölper S; Uhan S; Kaulich M; Wirth M; Keller U; Tascher G; Bohnsack KE; Müller S
    Nat Commun; 2023 Dec; 14(1):8121. PubMed ID: 38065954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYC as a regulator of ribosome biogenesis and protein synthesis.
    van Riggelen J; Yetil A; Felsher DW
    Nat Rev Cancer; 2010 Apr; 10(4):301-9. PubMed ID: 20332779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of the 5S RNP-Mdm2-p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia.
    Jaako P; Ugale A; Wahlestedt M; Velasco-Hernandez T; Cammenga J; Lindström MS; Bryder D
    Leukemia; 2017 Jan; 31(1):213-221. PubMed ID: 27256803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
    Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
    J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
    Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M
    Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p53 is positively regulated by miR-542-3p.
    Wang Y; Huang JW; Castella M; Huntsman DG; Taniguchi T
    Cancer Res; 2014 Jun; 74(12):3218-27. PubMed ID: 24762395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new PICTure of nucleolar stress.
    Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
    Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autogenous Control of 5′TOP mRNA Stability by 40S Ribosomes.
    Gentilella A; Morón-Duran FD; Fuentes P; Zweig-Rocha G; Riaño-Canalias F; Pelletier J; Ruiz M; Turón G; Castaño J; Tauler A; Bueno C; Menéndez P; Kozma SC; Thomas G
    Mol Cell; 2017 Jul; 67(1):55-70.e4. PubMed ID: 28673543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence.
    Fregoso OI; Das S; Akerman M; Krainer AR
    Mol Cell; 2013 Apr; 50(1):56-66. PubMed ID: 23478443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.
    Devlin JR; Hannan KM; Hein N; Cullinane C; Kusnadi E; Ng PY; George AJ; Shortt J; Bywater MJ; Poortinga G; Sanij E; Kang J; Drygin D; O'Brien S; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
    Cancer Discov; 2016 Jan; 6(1):59-70. PubMed ID: 26490423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
    Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
    Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of HDM2 activity by the ribosomal protein L11.
    Lohrum MA; Ludwig RL; Kubbutat MH; Hanlon M; Vousden KH
    Cancer Cell; 2003 Jun; 3(6):577-87. PubMed ID: 12842086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RP-Mdm2-p53 pathway and tumorigenesis.
    Miliani de Marval PL; Zhang Y
    Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of 5S rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and inhibits proliferation of esophageal squamous carcinoma cells.
    Wang X; Ren Y; Wang Z; Xiong X; Han S; Pan W; Chen H; Zhou L; Zhou C; Yuan Q; Yang M
    FEBS Lett; 2015 Dec; 589(24 Pt B):3989-97. PubMed ID: 26606907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
    Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.